Our portfolio

To date, CEPI has established multiple partnership agreements, reflecting a potential investment of up to $456 million. Through these collaborations, we're supporting the development of a wide range of vaccine candidates and platform technologies.

CEPI is also funding four programmes which aim to rapidly advance the development of vaccine candidates against the virus behind COVID-19.

These partnership agreements represent the start of CEPI’s product development portfolio.